Nexalin Technology Inc. (NXL)
NASDAQ: NXL
· Real-Time Price · USD
1.14
-0.05 (-4.20%)
At close: Jun 17, 2025, 3:59 PM
1.12
-1.75%
After-hours: Jun 17, 2025, 06:12 PM EDT
-4.20% (1D)
| Bid | 1.1 |
| Market Cap | 19.86M |
| Revenue (ttm) | 131.06K |
| Net Income (ttm) | -8.55M |
| EPS (ttm) | -0.84 |
| PE Ratio (ttm) | -1.36 |
| Forward PE | -2.15 |
| Analyst | Buy |
| Ask | 1.2 |
| Volume | 51,125 |
| Avg. Volume (20D) | 102,823 |
| Open | 1.16 |
| Previous Close | 1.19 |
| Day's Range | 1.11 - 1.18 |
| 52-Week Range | 0.59 - 4.49 |
| Beta | 4.05 |
Analyst Forecast
According to 0 analyst ratings, the average rating for NXL stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
-25.7%
Nexalin Technology shares are trading lower after ...
Unlock content with
Pro Subscription
7 months ago
+26.91%
Nexalin Technology shares are trading higher after the company announced it regained listing requirements compliance with Nasdaq.
1 year ago · proactiveinvestors.com
Nexalin Technology's neurostimulation device shows promise in easing mTBI symptoms in veteransNexalin Technology has unveiled positive results from a clinical study evaluating its Gen-2 tACS 15 milliamp neurostimulation device to reduce pain in veteran patients with mild Traumatic Brain Injury...
